Ascientist discovers that a compound inhibits the action of an enzyme. what experiment can he perform to determine whether the compound is a competitive or noncompetitive inhibitor?

Answer

Raise the concentrations of the reactants to see if activity can be restored through reactant competition with the inhibitor for binding at the active site.

Explanation:

Competitive inhibitors have a structure similar to that of the normal substrate. Like the substrate, the inhibitor binds temporarily to the enzyme's active site but is not converted to products. This way, the inhibitor competes with the normal substrate for binding onto the enzyme's active site.

Non-competitive inhibitors do not compete with the normal substrate for the active site. They bind at a site different from the active site in a way that alters the structure of the active site. The result is that the normal substrate fails to bind to the active site.

osteogenesis imperfecta (oi) refers to a congenital ailment of bones. in the condition, the bones become brittle or fragile. this ailment is a general result of the defect or mutations in the genes (colia1 or colia2). this mutation results in imperfect collagen formation either in quantity or quality wise.  

there are eight kinds of oi defects, and each kind varies with certain distinctions in symptoms. the usual symptoms include frequent bone fractures, loss of hearing in infants, protruding eyes, discoloration of the white in the eyes, respiratory issues, loosening of the joints, short stature, and other symptoms.  

they have identical fossils of organisms that have evolved over time.

both have animal fossils preserved in them due to weathering and erosion.

they contain different fossils because life on earth has changed through time.

the fossils in them were formed on the surface of earth due to exposure to sunlight.